Figure S2
Forest plots of the overall response rate (ORR) for celecoxib treatment combined with systematic therapy.
Figure S3
Forest plots of overall survival (OS) and progression-free survival (PFS), namely, OS-6 (A), OS-12 (B), PFS-6 (C), PFS-12 (D), for celecoxib treatment combined with systematic therapy. S1 Meta-analysis of the clinical endpoints in advanced NSCLC for celecoxib treatment combined with systematic therapy. Abbreviations: OR: odds ratio; CI: confidence interval; ORR: overall response rate;OS-6: 6month overall survival; OS-12: one-year overall survival; PFS-6: 6-month progression-free survival; PFS-12: 12-month progression-free survival; ≥2010: between January 1, 2010 and December 31, 2019; <2010: from January 1, 2001 and December 31, 2010.
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